About Christopher Palutis
Form D filings for Bridge Therapeutics in 2023 list Christopher Palutis as director.
Christopher Palutis first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Palutis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Palutis works with at each company, as listed on that company's latest Form D.
Bridge Therapeutics, Inc. · Form D, Dec 18, 2023
JM
Joseph Mullin
Director
EK
Elizabeth Kelley
Director
JB
Jason Bailey
Director
TP
Timothy Peara
President
JS
James Sullivan
Executive officer and director